Π‘Π°ΠΊΠ°Π»Π°Π²Ρ€
Π”ΠΈΠΏΠ»ΠΎΠΌΠ½Ρ‹Π΅ ΠΈ курсовыС Π½Π° Π·Π°ΠΊΠ°Π·

Π›ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π°. 
Π‘Ρ‚Π²ΠΎΠ»ΠΎΠ²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΈ старСниС

Π Π΅Ρ„Π΅Ρ€Π°Ρ‚ΠŸΠΎΠΌΠΎΡ‰ΡŒ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈΠ£Π·Π½Π°Ρ‚ΡŒ ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒΠΌΠΎΠ΅ΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹

Goldschmidt-Clermont PJ. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. Am Heart J. 2003;146(4 Suppl):S5βˆ’12. Roccanova L, Ramphal P. The role of stem cells in the evolution of longevity and its application to tissue therapy. Tissue Cell. 2003;35(1):79βˆ’81. Park SC, Cho KA, Jang IS, Kim KT, Ryu SJ. Functional efficiency of the senescent cells… Π§ΠΈΡ‚Π°Ρ‚ΡŒ Π΅Ρ‰Ρ‘ >

Π›ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π°. Π‘Ρ‚Π²ΠΎΠ»ΠΎΠ²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΈ старСниС (Ρ€Π΅Ρ„Π΅Ρ€Π°Ρ‚, курсовая, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½Π°Ρ)

1. Bell DR, Van Zant G. Stem cells, aging, and cancer: inevitabilities and outcomes. Oncogene. 2004;23(43):7290−6.

2. Benanti JA, Galloway DA. The normal response to RAS: senescence or transformation? Cell Cycle. 2004;3(6):715−7.

3. Beverley PC, Grubeck-Loebenstein B. Is immune senescence reversible? Vaccine. 2000; 25;18(16):1721−4.

4. Chen J. Senescence and functional failure in hematopoietic stem cells. Exp Hematol. 2004 ;32(11):1025−32.

5. de Haan G. Hematopoietic stem cells: self-renewing or aging? Cells Tissues Organs. 2002;171(1):27−37.

6. Donehower LA. Does p53 affect organismal aging? J Cell Physiol. 2002 ;192(1):23−33.

7. Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol. 2002 ;3(4):329−33.

8. Globerson A. Hematopoietic stem cells and aging. Exp Gerontol. 1999;34(2):137−46.

9. Globerson A. Haematopoietic stem cell ageing. Novartis Found Symp. 2001;235:85−96; discussion 96−100, 101−4.

10. Globerson A, Barzilai N. The voyage to healthy longevity: from experimental models to the ultimate goal. Mech Ageing Dev. 2005;126(2):225−9.

11. Goldschmidt-Clermont PJ. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. Am Heart J. 2003;146(4 Suppl):S5−12.

12. Grossman T. Latest advances in antiaging medicine. Keio J Med. 2005;54(2):85−94.

13. Harley CB. Human ageing and telomeres. Ciba Found Symp. 1997;211:129−39.

14. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol. 2002 ;2(9):699−706.

15. Johnson TE. Genetic influences on aging. Exp Gerontol. 1997;32(1−2):11−22.

16. Kucia M, Ratajczak J, Ratajczak MZ. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol Cell. 2005;97(2):133−46.

17. Koli K, Keski-Oja J. Cellular senescence. Ann Med. 1992;24(5):313−8.

18. Krtolica A. Stem cell: balancing aging and cancer. Int J Biochem Cell Biol. 2005 ;37(5): 935−41.

19. Liang Y, Van Zant G. Genetic control of stem-cell properties and stem cells in aging. Curr Opin Hematol. 2003;10(3):195−202.

20. Miura T, Mattson MP, Rao MS. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell. 2004;3(6):333−43.

21. Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation. J Clin Invest. 2004;113(2):175−9.

22. Park SC, Cho KA, Jang IS, Kim KT, Ryu SJ. Functional efficiency of the senescent cells: replace or restore? Ann N Y Acad Sci. 2004;1019:309−16.

23. Pelicci PG. Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J Clin Invest. 2004;113(1):4−7.

24. Pinto A, De Filippi R, Frigeri F, Corazzelli G, Normanno N. Aging and the hemopoietic system. Crit Rev Oncol Hematol. 2003;48(Suppl):S3-S12.

25. Rao MS, Mattson MP. Stem cells and aging: expanding the possibilities. Mech Ageing Dev. 2001; 31;122(7):713−34.

26. Ratajczak MZ, Kucia M, Majka M, Reca R, Ratajczak J. Heterogeneous populations of bone marrow stem cells—are we spotting on the same cells from the different angles? Folia Histochem Cytobiol. 2004;42(3):139−46.

27. Roccanova L, Ramphal P. The role of stem cells in the evolution of longevity and its application to tissue therapy. Tissue Cell. 2003;35(1):79−81.

28. Sharpless NE. Ink4a/Arf links senescence and aging. Exp Gerontol. 2004;39(11−12):1751−9.

29. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest. 2004;113(2):160−8.

30. Schlessinger D, Van Zant G. Does functional depletion of stem cells drive aging? Mech Ageing Dev. 2001; 30;122(14):1537−53.

31. Stanulis-Praeger BM. Cellular senescence revisited: a review. Mech Ageing Dev. 1987 ;38(1):1−48.

32. Ukraintseva SV, Yashina AI. Cancer as «rejuvenescence». Ann N Y Acad Sci. 2004 ;1019:200−5.

33. Van Zant G. Genetic control of stem cells: implications for aging. Int J Hematol. 2003 ;77(1):29−36.

34. Van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol. 2003;31(8):659−72.

35. von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med. 2005;5(2):197−203.

36. Weng NP, Hodes RJ. The role of telomerase expression and telomere length maintenance in human and mouse. J Clin Immunol. 2000;20(4):257−67.

37. Yegorov YE, Zelenin AV. Duration of senescent cell survival in vitro as a characteristic of organism longevity, an additional to the proliferative potential of fibroblasts. FEBS Lett. 2003; 24;541(1−3):6−10.

ΠŸΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ вСсь тСкст
Π—Π°ΠΏΠΎΠ»Π½ΠΈΡ‚ΡŒ Ρ„ΠΎΡ€ΠΌΡƒ Ρ‚Π΅ΠΊΡƒΡ‰Π΅ΠΉ Ρ€Π°Π±ΠΎΡ‚ΠΎΠΉ